Summary
Long noncoding RNA (lncRNA) urothelial carcinoma associated 1 (UCA1) has been reported to be highly expressed in many kinds of cancers. This meta-analysis summarized its potential prognostic value in digestive system malignancies. A meta-analysis was performed through a comprehensive search in PubMed, EMBASE, the Cochrane Library, Web of Science and Chinese National Knowledge Infrastructure (CNKI) for suitable articles on the prognostic impact of UCA1 in digestive system malignancies from inception to June 27, 2019. Pooled hazard ratios (HRs) with 95% confidence interval (95%CI) were calculated to summarize the effect. Sixteen studies were included in the study, with a total of 1504 patients. A significant association was observed between UCA1 abundance and poor overall survival (OS), and shorter disease-free survival (DFS) for patients with digestive system malignancies, with pooled HR of 2.07 (95%CI: 1.74–2.47), and of 2.50 (95%CI: 1.62–3.86). Subgroup analysis and sensitivity analysis suggested the reliability of our findings. It is suggested that UCA1 abundance may serve as a reliable predictive factor for poor prognosis in patients with digestive system malignancies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Lin Y, Liu Z, Qiu Y, et al. Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. Eur J Surg Oncol, 2018,44(10):1494–1503
Yin C, Zhou X, Dang Y, et al. Potential Role of Circulating MiR-21 in the Diagnosis and Prognosis of Digestive System Cancer: A Systematic Review and Meta-Analysis. Medicine, 2015,94(50):e2123
Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet, 2009,5(4):e1000459
Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci, 2012,13(8):528–541
Sun Y, Wang Z, Zhou D. Long non-coding RNAs as potential biomarkers and therapeutic targets for gliomas. Med Hypotheses, 2013,81(2):319–321
Furlan G, Rougeulle C. Function and evolution of the long noncoding RNA circuitry orchestrating X-chromosome inactivation in mammals. Wiley Interdiscip Rev RNA, 2016,7(5):702–722
Arun G, Diermeier S, Akerman M, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Gene Dev, 2016,30(1):34–51
Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci, 2016,73(13):2491–2509
Taft RJ, Pang KC, Mercer TR, et al. Non-coding RNAs: regulators of disease. J Pathol, 2010,220(2):126–139
Xue M, Pang H, Li X, et al. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci, 2016,107(1):18–27
Wang XS, Zhang ZH, Cai JL, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res, 2006,12(16):4851–4858
Wang Y, Chen W, Yang C, et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol, 2012,41 (1):276
Li JY, Ma X, Zhang CB. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol, 2014,7(11):7938–7944
Xue M, Li X, Wu W, et al. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis. Oncol Rep, 2014,31(5):1993–2000
Na XY, Liu ZY, Ren PP, et al. Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med, 2015,8(8):12609–12616
Shang C, Guo Y, Zhang J, et al. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Cancer Chemother Pharmacol, 2016,77(5):1061–1067
Zheng Q, Wu F, Dai WY, et al. Aberrant expression of UCA1 in gastric cancer and its clinical significance. Clin Transl Oncol, 2015,17(8):640–646
Ni B, Yu X, Guo X, et al. Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer. Int J Oncol, 2015,47(4):1329–1338
Tao K, Yang J, Hu Y, et al. Clinical significance of urothelial carcinoma associated 1 in colon cancer. Int J Clin Exp Med, 2015,8(11):21 854–21 860
Yang Z, Lu Y, Xu Q, et al. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus. Dis Markers, 2015,2015:191029
McShane LM, Altman DG, Sauerbrei W, et al. REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat, 2006,100(2):229–235
Sauerbrei W, Taube SE, McShane LM, et al. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration. J Natl Cancer Inst, 2018,110(8):803–811
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010,25(9): 603–605
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med, 2002,21(11):1539–1558
Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ, 2003,327(7414): 557–560
Noyes J, Popay J, Pearson A, et al. Qualitative research and Cochrane reviews. Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series. John Wiley & Sons, Ltd, 2008.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics, 1994,50(4):1088–1101
Egger M. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997,315:629–634
Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 2015,56(2):455–463
Bian Z, Jin L, Zhang J, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep, 2016,6:23892
Chen DT, Davis-Yadley AH, Huang PY, et al. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma. PloS One, 2015, 10(8): e0133562
Chen P, Wan D, Zheng D, et al. Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer. Biomed Pharmacother, 2016,83:1220–1226
Fu XL, Liu DJ, Yan TT, et al. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma. Sci Rep, 2016,6:33535
Gao J, Cao R, Mu H. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer. Int J Clin Exp Pathol, 2015,8(10):12936
Jiang H, Chen YT, Fu XG. Tissue expression level of lncRNA UCA1 is a prognostic biomarker for colorectal cancer. Int J Clin Exp Pathol, 2016,9(4):4241–4246
Jiao C, Song Z, Chen J, et al. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. Oncol Rep, 2016,36(5):2960
Wang F, Ying HQ, He BS, et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget, 2015,6(10):7899–7917
Yu H, Ying-Nan Y, Heng-Heng Y, et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology, 2014,46(5):396–401
Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nature Rev Genet, 2009,10(3):155–159
Gibb EA, Brown CJ, Wan LL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 2011,10:38
Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nature Rev Genet, 2011, 12(2):136–149
Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov, 2011,1(5): 391
Nobili L, Lionetti M, Neri A. Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget, 2016,7(31):50 666–50 681
Wang F, Li X, Xie XJ, et al. UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett, 2008,582(13):1919–1927
Author information
Authors and Affiliations
Corresponding author
Additional information
Conflict of Interest Statement
The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.
Rights and permissions
About this article
Cite this article
Shi, Ft., Chen, Ld. & Zhang, Lf. Long Noncoding RNA UCA1 Overexpression Is Associated with Poor Prognosis in Digestive System Malignancies: A Meta-analysis. CURR MED SCI 39, 694–701 (2019). https://doi.org/10.1007/s11596-019-2094-3
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-019-2094-3